SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who wrote (11)1/28/1999 3:11:00 PM
From: Bo Didley  Read Replies (3) of 5582
 
$4.60 Gross /unit of ZICAM
by: CapnJon7737 1676 of 1680

I have a retail price on Zicam at $12.95 a unit. ( I had to bribe my grocer at Albertsons w/ a hot stock tip, to get this info, hmmmm). Even at that the numbers I am giving are not cast in stone.

The usual mark up on such items is around 80%, 0r a 40% margin; that would give 60% back to Gumm which owms a 60% share in the
product. This gives a rough number of $4.66 per unit devolving back to Gumm. Why I took .06 off was to please the shorters....
===

my thoughts:
If Zicam treats 1% or 2% of the 1 Billion Colds in the US
this year alone, this stock will be worth a lot of money.

The growth potential for the cold market is phenomenal,
particularly if you have the only product that will reduce
a cold to 1 1/2 days, rather than enduring a cold for 14 days.

bo

ps: there are no new shorters in this stock because shares
are not borrowable. There are a few very long term shorters
who are at yahoo mgs board. They will soon get a big margin call.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext